title: The use of inferior vena cava filter as a treatment modality for massive pulmonary embolism. A case series and review of pathophysiology.
abstract: The use of inferior vena cava (IVC) filter for massive pulmonary emboli (PE) with cardiopulmonary instability has not been clinically studied. We present a case series of six such patients who received an IVC filter with anticoagulation rather than thrombolysis because of high risk of bleeding. Acute pulmonary embolectomy was considered, but was not possible for a variety of individual clinical situations. These six hospitalized patients prospectively followed during their admission. They were triaged to three medical intensive care units (ICUs) and one surgical ICU in three university teaching hospitals. One patient was transferred from another institution. All six patients had severe hypoxia and tenuous cardiopulmonary status. All required high inspiratory oxygen and hemodynamic support; two required mechanical ventilation and vasopressors. An IVC filter was placed emergently and anticoagulation was started immediately All six patients had resolution of pulmonary thromboemboli (PTE) on anticoagulation while the IVC filter prevented further PE. All six patients were discharged home in their pre-critical illness state. None ofthe patients suffered complications from this therapy and had excellent resolution ofcardiopulmonary collapse. The IVC filter placement prevented further major embolic events while the PTE resolved with anticoagulation. An IVC filter should be considered as an adjunct to anticoagulation therapy for those patients with massive PE and cardiopulmonary instability who are not candidates for thrombolysis, and acute pulmonary embolectomy is not readily available or is of very high risk.
authors.affiliation: deshpandek@aol.com
authors.forename: K S
authors.initials: KS
authors.lastname: Deshpande
authors.forename: C
authors.initials: C
authors.lastname: Hatem
authors.forename: M
authors.initials: M
authors.lastname: Karwa
authors.forename: H
authors.initials: H
authors.lastname: Ulrich
authors.forename: T K
authors.initials: TK
authors.lastname: Aldricht
authors.forename: V
authors.initials: V
authors.lastname: Kvetan
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000627:therapeutic use; D000075202:Contraindications; D004630:Emergencies; D005260:Female; D006801:Humans; D008168:Lung / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011655:Pulmonary Embolism / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D015912:Thrombolytic Therapy; D016306:Vena Cava Filters
chemical_list: D000925:Anticoagulants